Naprosyn
These highlights do not include all the information needed to use NAPROSYN Tablets, EC-NAPROSYN and ANAPROX DS safely and effectively. See full prescribing information for NAPROSYN, EC-NAPROSYN and ANAPROX DS. NAPROSYN (naproxen) tablets, EC-NAPROSYN (naproxen delayed-release tablets), ANAPROX DS (naproxen sodium tablets), for oral use Initial U.S. Approval: 1976
8bff5df5-d856-4237-b6a8-ae445b454844
HUMAN PRESCRIPTION DRUG LABEL
Apr 30, 2021
Canton Laboratories
DUNS: 079589614
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
naproxen sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
naproxen
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
naproxen
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
naproxen
Product Details
FDA regulatory identification and product classification information